Clinical Trial Update: ENDOCARE-SCREEN: Metabolic Liver Dysfunction Screening Study

View source ↗

Summary

ENDOCare-SCREEN is a screening study for metabolic liver dysfunction and related metabolic conditions, currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance Syndrome
• Metabolic Dysfunction-associated Steatotic Liver Disease
• Metabolic Syndrome
• Nonalcoholic Steatohepatitis
• Obesity
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Jarosław Drobnik | Conditions: Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH), Metabolic Syndrome | Status: NOT_YET_RECRUITING